Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

123 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cytokines in cancer immunity and immunotherapy.
Smyth MJ, Cretney E, Kershaw MH, Hayakawa Y. Smyth MJ, et al. Among authors: kershaw mh. Immunol Rev. 2004 Dec;202:275-93. doi: 10.1111/j.0105-2896.2004.00199.x. Immunol Rev. 2004. PMID: 15546400 Review.
Cytotoxic lymphocytes: redirecting the cell-mediated immune response for the therapy of cancer.
Kershaw MH, Trapani JA, Smyth MJ. Kershaw MH, et al. Ther Immunol. 1995 Jun;2(3):173-81. Ther Immunol. 1995. PMID: 8885135 Review.
Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors.
Haynes NM, Trapani JA, Teng MW, Jackson JT, Cerruti L, Jane SM, Kershaw MH, Smyth MJ, Darcy PK. Haynes NM, et al. Among authors: kershaw mh. Blood. 2002 Nov 1;100(9):3155-63. doi: 10.1182/blood-2002-04-1041. Blood. 2002. PMID: 12384413
Rejection of syngeneic colon carcinoma by CTLs expressing single-chain antibody receptors codelivering CD28 costimulation.
Haynes NM, Trapani JA, Teng MW, Jackson JT, Cerruti L, Jane SM, Kershaw MH, Smyth MJ, Darcy PK. Haynes NM, et al. Among authors: kershaw mh. J Immunol. 2002 Nov 15;169(10):5780-6. doi: 10.4049/jimmunol.169.10.5780. J Immunol. 2002. PMID: 12421958
Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway.
Westwood JA, Kelly JM, Tanner JE, Kershaw MH, Smyth MJ, Hayakawa Y. Westwood JA, et al. Among authors: kershaw mh. J Immunol. 2004 Jan 15;172(2):757-61. doi: 10.4049/jimmunol.172.2.757. J Immunol. 2004. PMID: 14707044
Discovery of an innate cancer resistance gene?
Smyth MJ, Kershaw MH. Smyth MJ, et al. Among authors: kershaw mh. Mol Interv. 2003 Jun;3(4):186-9. doi: 10.1124/mi.3.4.186. Mol Interv. 2003. PMID: 14993445 No abstract available.
A functional role for CD28 costimulation in tumor recognition by single-chain receptor-modified T cells.
Moeller M, Haynes NM, Trapani JA, Teng MW, Jackson JT, Tanner JE, Cerutti L, Jane SM, Kershaw MH, Smyth MJ, Darcy PK. Moeller M, et al. Among authors: kershaw mh. Cancer Gene Ther. 2004 May;11(5):371-9. doi: 10.1038/sj.cgt.7700710. Cancer Gene Ther. 2004. PMID: 15060573
Immunotherapy of cancer using systemically delivered gene-modified human T lymphocytes.
Teng MW, Kershaw MH, Moeller M, Smyth MJ, Darcy PK. Teng MW, et al. Among authors: kershaw mh. Hum Gene Ther. 2004 Jul;15(7):699-708. doi: 10.1089/1043034041361235. Hum Gene Ther. 2004. PMID: 15242530
Gene-engineered T cells as a superior adjuvant therapy for metastatic cancer.
Kershaw MH, Jackson JT, Haynes NM, Teng MW, Moeller M, Hayakawa Y, Street SE, Cameron R, Tanner JE, Trapani JA, Smyth MJ, Darcy PK. Kershaw MH, et al. J Immunol. 2004 Aug 1;173(3):2143-50. doi: 10.4049/jimmunol.173.3.2143. J Immunol. 2004. PMID: 15265951
Gene modification strategies to induce tumor immunity.
Murphy A, Westwood JA, Teng MW, Moeller M, Darcy PK, Kershaw MH. Murphy A, et al. Among authors: kershaw mh. Immunity. 2005 Apr;22(4):403-14. doi: 10.1016/j.immuni.2005.03.007. Immunity. 2005. PMID: 15845446 Review.
123 results
Jump to page
Feedback